These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 18990139)

  • 1. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
    Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
    BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS
    Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
    Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
    J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
    Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
    J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
    Bolenz C; Shariat SF; Fernández MI; Margulis V; Lotan Y; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Montorsi F; Bensalah K; Wood CG; Roscigno M; Langner C; Koppie TM; Raman JD; Mikami S; Michel MS; Ströbel P
    BJU Int; 2009 Feb; 103(3):302-6. PubMed ID: 18990164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
    Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF
    BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
    Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M
    J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
    Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
    Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
    J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.
    Bolenz C; Fernández MI; Trojan L; Herrmann E; Becker A; Weiss C; Alken P; Ströbel P; Michel MS
    Urology; 2008 Aug; 72(2):364-9. PubMed ID: 18579189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
    Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
    Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
    Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
    Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
    Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.